ǰÑÔ
°¢¶û´Äº£Ä¬²¡(Alzheimer's disease,AD)ÓÖ³ÆÍíÄêÐÔ³Õ´ô£¬ÊÇ×î³£¼ûµÄ³Õ´ôÀàÐÍ£¬Õ¼ËùÓгմô²¡ÀýµÄ2/3¡£ÆäÁÙ´²ÌØÕ÷Ϊ¾ÙÐÐÐÔ³Õ´ô£¬ÌåÏÖΪӰÏó¼õÍË¡¢ÈÏÖªÕϰºÍÈ˸ñ¸Ä±äµÈ¡£Ö÷Òª²¡ÀíÌØÕ÷Ϊ´óÄÔÆ¤Öʺͺ£ÂíÇø·ºÆðÍíÄê°ß(senile plaque,SP)¡¢Éñ¾ÔªÄÚÉñ¾ÔÏËά²ø½á(neurofibrillary tangle, NFT£©ºÍÉñ¾Ñ×Ö¢¡£¾Ý½üÄêµÄ×ÊÁÏͳ¼Æ£¬È«ÌìÏÂÓÐ3500ÍòAD»¼Õß¡£ÔÚÖйú£¬AD»¼ÕßÒÔÿÄê30¶àÍòµÝÔö£¬Õâ¶ÔÒѾ½øÈëÍíÄ껯Éç»áµÄÖйúÕþ¸®ºÍÉç»á¼°Ð¡ÎÒ˽¼Ò¶øÑÔ¶¼´øÀ´¼«Öصļ縺¡£×èÖ¹ÏÖÔÚ£¬Õë¶ÔADÉÐÎÞÓÐÓõÄÖÎÓúÒªÁ죬ΪÁËÔöÇ¿ÁÙ´²Ò½Ñ§×ª»¯Ñо¿ÒÔ¼°ÁÙ´²Ç°Ò©Îïɸѡ£¬ÎÒÃÇÆÈÇÐÐèÒªÉú³¤ºÍ¿ª·¢Ïà¹ØµÄ¶¯ÎïÄ£×Ó¡£
AD¶¯ÎïÄ£×ÓÊÇÒÔʵÑ鶯ÎïÄ£ÄâAD»¼ÕßÄÔ×éÖ¯µÄ²¡Àíת±ä¼°ÐÐÎªÌØÕ÷¡£ÏÖÔÚAD¶¯ÎïÄ£×Ó´ó¶àÖ»ÄÜÄ£ÄâADijЩ²¡±ä»òÕßÖ¢×´£¬ÍêÈ«ÇкÏÈËÀàAD²¡±äµÄ¶¯ÎïÄ£×ÓÉÐδÎÊÊÀ¡£¿ÉÊÇ£¬Ëæ×Å·Ö×ÓÉñ¾ÉúÎïѧµÄÉú³¤£¬Ò»Ö±ÓиüΪϸÄåµÄ¸üÇкÏAD²¡±ä±¬·¢Éú³¤Àú³ÌµÄ¶¯ÎïÄ£×ÓÑÐÖÆ³öÀ´£¬Îª½øÒ»²½Ã÷È·ADµÄ·¢²¡»úÖÆÊ©Õ¹Ö÷ÒªµÄ×÷Óá£
´ÓADÄ£×ÓÖÆ×÷ºÍÓ¦ÓÃÀúÊ·À´¿´£¬ÒÔ»ùÒò¹¤³ÌÊÖÒÕÖÆ×÷µÄAD¶¯ÎïÄ£×Ó»ñµÃÔ½À´Ô½ÆÕ±éµÄÓ¦Ó㬠¶øÒÔ»¯Ñ§¶¾Îï»òÎïÀíËðÉËÌØ¶¨²¿Î»µÄADÔìÄ£·½·¨ÓÉÓÚ±£´æ°Ðλ²»×¼È·£¬Îó²î´ó£¬Ó¦ÓÃÔ½À´Ô½ÉÙ¡£Òò´Ë£¬ÔÚADµÄ¶¯ÎïÄ£×ÓÖУ¬ÎÒÃǽ«×ÅÖØÏÈÈÝÒÔ»ùÒò¹¤³ÌÊÖÒÕÖÆ×÷µÄ»ùÒòÐÞÊÎAD¶¯ÎïÄ£×Ó¡£
AD¶à±¬·¢ÓÚÍíÄêÈË£¬ÊÇÒ»ÖÖ¸úÄêËêÏà¹ØµÄ¼²²¡¡£ÐàÂõÔÚAD·¢²¡Àú³ÌÖÐÊÎÑÝ×ÅÖ÷ÒªµÄ½ÇÉ«¡£´ËÀàÄ£×ÓÊÇÒÔÐàÂõΪAD·¢²¡Ôµ¹ÊÔÓÉ£¬Í¨¹ýÖÖÖÖÒªÁì¡¢ÊÖ¶ÎÔö½ø¶¯ÎïµÄÐàÂõ£¨°üÀ¨×ÔÈ»ÐàÂõ£©À´µÖ´ïÖÆ×÷AD¶¯ÎïÄ£×ÓµÄÄ¿µÄ¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎСÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
ÓÉÎÒ¹úѧÕßÊ×ÏÈÌá³ö£¬D-°ëÈéÌÇ(D-galactose)¿Éµ¼Ö»úÌåÌǺÍÂѰ×ÖÊ´úлÔÓÂÒ£¬·ºÆðÐàÂõÌØÕ÷¡£
¡¾Ä£×ÓÌØµã¡¿£º
½«D£°ëÈéÌÇ×¢ÈëСÊó¾±²¿Æ¤·ôÓÕ·¢ADÖ¢×´£¬ÌåÏÖΪѧϰӰÏóÄÜÁ¦Ï½µ¡¢Ðж¯»ºÂý¡¢Ã«·¢Ï£º±µÈÀÏ»¯±íÕ÷¡£½øÒ»²½µÄ²¡Àí¼ì²é·¢Ã÷ƤÖÊÉñ¾ÔªÏßÁ£ÌåÅòÕͳɿÕÅÝÑù¸Ä±ä£¬´ÖÃæÄÚÖÊÍø¿ÅÁ£ïÔÌ£¬ÂѰ×ÖʺϳÉïÔÌ£¬Éñ¾ÔªÉ¥Ê§¡£
¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º
ͨ¹ýÄ£ÄâÐàÂõÀú³Ì¶ø»ñµÃµÄ¶¯ÎïÄ£×Ó½ÏÕæÊµµØÔÙÏÖADµÄ²¡Àí¸Ä±ä£¬µ«ÐàÂõÖ»ÊÇAD·¢²¡µÄΣÏÕÒòËØ£¬ADÊÇÔÚÐàÂõµÄ»ù´¡Éϱ¬·¢²¡Àí¸Ä±ä£¬²î±ðÓÚÕý³£µÄÐÄÀíÐàÂõÀú³Ì£¬Òò´ËÐàÂõ¶¯ÎïÄ£×Ó²»¿ÉÕæÕýÈ¡´úADÄ£×Ó¡£
²Î¿¼ÎÄÏ×£º
1.Andrä K, Abramowski D, Du.ke M, et al. Expression of APP in transgenic mice:a comparison of neuron-specific promoters. Neurobiol Aging, 1996, 17 (2):183-190
2.Chishti MA, Yang DS, Janus C, et al. EarJy-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of arnyloid precursor protein 695. J Biol Chem,2001,276(24):21562-21570
3.Games D,Adams D,Alessandrini R,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyl,0id precursor protein. Nature, 1995,373(6514): 523-527
4.Hsiao K,Chapman P,Nilsen S,et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science, 1996,274(5284):99-102
5.Oddo S,Caccamo A,Shepherd JD,et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron, 2003, 39 (3):409-421
6.Perez M, Ri be E, Rubio A, el al. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation. Neuroscience, 2005, 130 (2):339-347
7.Rhein V, Song X, Wiesner A, et al. Arnyloid-beta and tau synergistically impair the oxidative phosphorylation ystem in lriple transgenic Alzheimer's disease mice. Proc Natl Acad Sci USA,2009, 106 (47):20057-20062